Brief: Orchid Pharma Says Alathur API Facility Successfully Completes USFDA Inspection
19/02/2025 12:40
Feb 19 (Reuters) - Orchid Pharma Ltd ORCD.NS :
* ORCHID PHARMA LTD - ALATHUR API FACILITY SUCCESSFULLY
COMPLETES
USFDA INSPECTION
* ORCHID PHARMA LTD - SECURES EU GMP CERTIFICATE RENEWAL FOR
CEPHALOSPORIN API MANUFACTURING
* ORCHID PHARMA LTD - USFDA INSPECTION RESULTS IN SEVEN
MINOR
OBSERVATIONS
Source text: ID:
Further company coverage: ORCD.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Orchid Pharma
See all newsBrief: Orchid Pharma Approves Enabling Resolution To Explore Fund Raising Via Equity Or Other Securities
Brief: Orchid Pharma To Consider And Evaluate Various Options For Raising Funds
Brief: Orchid Pharma June-Quarter Consol Profit 25.8 Million Rupees
India's Orchid Pharma jumps on pact to commercialize Exblifep in Russia
Refile: INDIA STOCKS-Indian shares set to open lower as US-Iran tensions lift oil prices